Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells
about
Identification and characterization of a novel androgen receptor coregulator ARA267-alpha in prostate cancer cellsSuppression of estrogen receptor-mediated transcription and cell growth by interaction with TR2 orphan receptorBRCA1 mediates ligand-independent transcriptional repression of the estrogen receptorAkt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptorBRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cellsThe androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriersT:G mismatch-specific thymine-DNA glycosylase (TDG) as a coregulator of transcription interacts with SRC1 family members through a novel tyrosine repeat motif.The convergence of DNA damage checkpoint pathways and androgen receptor signaling in prostate cancerT:G mismatch-specific thymine-DNA glycosylase potentiates transcription of estrogen-regulated genes through direct interaction with estrogen receptor alphaBARD1 induces BRCA1 intranuclear foci formation by increasing RING-dependent BRCA1 nuclear import and inhibiting BRCA1 nuclear exportSuppression of androgen receptor-mediated transactivation and cell growth by the glycogen synthase kinase 3 beta in prostate cellsIdentification and characterization of a tissue-specific coactivator, GT198, that interacts with the DNA-binding domains of nuclear receptors.BRCA1 and Oxidative StressPhosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligaseCancer biomarker discovery: the entropic hallmark.Suppression of androgen receptor transactivation by Pyk2 via interaction and phosphorylation of the ARA55 coregulator.Transcription factor and microRNA regulation in androgen-dependent and -independent prostate cancer cells.The ordering of expression among a few genes can provide simple cancer biomarkers and signal BRCA1 mutations.The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells.BRCA1 and BRCA2 mutations and treatment strategies for breast cancer.Differential modulation of androgen receptor-mediated transactivation by Smad3 and tumor suppressor Smad4.BRCA1 transcriptionally regulates genes involved in breast tumorigenesis.Tumor suppressor BRCA1 is expressed in prostate cancer and controls insulin-like growth factor I receptor (IGF-IR) gene transcription in an androgen receptor-dependent manner.Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function.The wedelolactone derivative inhibits estrogen receptor-mediated breast, endometrial, and ovarian cancer cells growthThe androgen receptor acetylation site regulates cAMP and AKT but not ERK-induced activity.Modulation of the tumor cell death pathway by androgen receptor in response to cytotoxic stimuli.Research resource: EPSLiM: ensemble predictor for short linear motifs in nuclear hormone receptors.MDC1 functionally identified as an androgen receptor co-activator participates in suppression of prostate cancer.Expression and function of nuclear receptor co-activator 4: evidence of a potential role independent of co-activator activity.Dehydroepiandrosterone, androgens and the mammary gland.Androgen receptor as a target for the treatment of hormone receptor-negative breast cancer: an unchartered territory.ARTIK-52 induces replication-dependent DNA damage and p53 activation exclusively in cells of prostate and breast cancer origin.Subfertility and defective folliculogenesis in female mice lacking androgen receptor.Profiling of Cross-Functional Peptidases Regulated Circulating Peptides in BRCA1 Mutant Breast Cancer.The Correlation Between PARP1 and BRCA1 in AR Positive Triple-negative Breast Cancer.Genomic instability in breast and ovarian cancers: translation into clinical predictive biomarkers.The pharmacogenomics of sex hormone metabolism: breast cancer risk in menopausal hormone therapy.The androgen receptor interacts with multiple regions of the large subunit of general transcription factor TFIIF.Androgen receptor-related diseases: what do we know?
P2860
Q24291571-DD4B0AE0-43CC-4CB2-8EC1-C8A04650F209Q24300794-EECB64E5-9E2D-435A-8389-8750A4717E71Q24555775-58F3A562-A404-47AA-B202-4C4AE8C3D39FQ24631156-4E8C7833-0580-4BCF-8F94-5510149FDC14Q24652441-9B165940-8A9B-40A0-9405-EBA2A3C96863Q24797305-6F871904-3199-4F99-8472-A857B4EB9CE6Q24817047-EF01E901-DFD8-4055-8AC3-90A4C1988F12Q27014101-98314721-F728-46C9-90DF-1A8C98AC25E7Q28188710-329BD64E-E16B-4FB9-88EB-04A7ABFA56ECQ28211710-412B5686-7FBD-4597-A250-6E1CE27612ACQ28265036-16A7A0CB-3241-4E09-8BDE-C73249F61425Q28366099-A1FCB81F-674C-4F0C-86F3-428C8DD2D170Q28388921-AC1FA3B3-727E-42B9-9496-9DD6254F51DFQ28511501-2947C351-90A2-4F2E-A481-E0E6518EBBFFQ30496149-03F135EC-3D6C-4E83-AF44-37A9A50F039CQ30816464-1B493B98-B1D8-41D8-B170-26E476B526B1Q33373567-CD3BE53D-C046-47C3-BEA3-5D2D88067A73Q33495401-592B7B2E-BD25-47B8-ADC8-EC1A75229005Q33652431-8A7824A9-40DD-4D55-832A-23B2322CDB97Q33894431-D5306E22-EAD2-4BCB-8E36-86B9416F9A25Q33961300-0318B5C3-2717-4C83-BC0A-CB8BED07F70CQ34064538-140256D6-CA90-4515-B7F4-CDA8C6A15012Q34109373-3B328772-F133-452C-B05F-1277C9AD4004Q34125103-608011D5-8294-4337-B275-4E38E69D7F4CQ34147026-45C72008-EDAA-45A5-A01B-F5A81F335737Q34318315-1DC81D27-5538-4A64-B7CD-AF7674B0A3BBQ35100137-293CC555-CC62-4EDF-8380-7FBFA9A968ACQ35134266-A5F7E979-B231-4DA2-88C6-1C35F328B201Q35656832-3C5EB449-2E71-4760-8BB4-142CBCDD4615Q36382025-77C9EBB8-22B9-4A22-9AA0-0A284CC851CEQ36533630-B0C9F265-D5E1-4B42-96D5-6B7CC7C6F92BQ37074119-1F0EEAFD-B2B9-4A3C-90E9-4912FD1D59F1Q37091948-9BAC2318-87B8-461A-8A3C-6BBC13234FC3Q37388507-FA213B5B-076F-4C55-A6F1-B78B34B6FE53Q37443351-BC58632A-1F6D-4BED-9F49-1193050D1FADQ37513919-FA48CB91-BA0A-4B7B-8770-E1A2B5049CF5Q37933098-350E366D-E41E-42A8-BDB5-DB9E8F2387A2Q38003702-52E88F95-CDA3-471C-9965-4ADCC1235447Q38363646-3B198CF4-5B41-43AC-9C18-9E59FE8DCF47Q38780007-CF5BC53F-EA71-4B24-B476-4DBB41EFA7F8
P2860
Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Increase of androgen-induced c ...... BRCA1 in prostate cancer cells
@ast
Increase of androgen-induced c ...... BRCA1 in prostate cancer cells
@en
Increase of androgen-induced c ...... BRCA1 in prostate cancer cells
@nl
type
label
Increase of androgen-induced c ...... BRCA1 in prostate cancer cells
@ast
Increase of androgen-induced c ...... BRCA1 in prostate cancer cells
@en
Increase of androgen-induced c ...... BRCA1 in prostate cancer cells
@nl
prefLabel
Increase of androgen-induced c ...... BRCA1 in prostate cancer cells
@ast
Increase of androgen-induced c ...... BRCA1 in prostate cancer cells
@en
Increase of androgen-induced c ...... BRCA1 in prostate cancer cells
@nl
P2093
P2860
P356
P1476
Increase of androgen-induced c ...... BRCA1 in prostate cancer cells
@en
P2093
P2860
P304
P356
10.1073/PNAS.190353897
P407
P577
2000-10-10T00:00:00Z